uric acid has been researched along with transforming growth factor beta in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 7 (26.92) | 29.6817 |
| 2010's | 9 (34.62) | 24.3611 |
| 2020's | 8 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Bardin, T; Champy, R; Herbelin, A; Lioté, F; Ortiz-Bravo, E; Prudhommeaux, F; Schiltz, C | 1 |
| de Waart, DR; Krediet, RT; Smit, W; Struijk, DG; Zweers, MM | 1 |
| Oliviero, F; Punzi, L | 1 |
| Evans, BJ; Florey, O; Haskard, DO; Landis, RC; Mason, JC; Yagnik, DR | 1 |
| Barsky, L; Buckley, S; Warburton, D; Weinberg, K | 1 |
| Agha-Babakhani, A; Johnson, K; Rose, DM; Sydlaske, AD; Terkeltaub, R | 1 |
| Bowler, RP; Crapo, JD; Regan, EA | 1 |
| Flavell, RA; Gomes, DA; Hashmi, A; Jhandier, MN; Mahmood, S; Mehal, WZ; Nagata, J; Shi, Y; Sohail, MA; Sutterwala, FS; Watanabe, A | 1 |
| Duan, H; Li, Y; Liu, H; Liu, Q; Liu, S; Shi, Y; Wang, H; Wang, XM | 1 |
| Chiou, HY; Lai, SH; Lo, HC; Wang, YH; Yang, Y | 1 |
| Ea, HK | 1 |
| Busso, N; Ea, HK | 1 |
| Bao, W; Cheng, SB; Chin, YE; Liu, N; Qiu, A; Shi, Y; Wang, L; Xiong, C; Xu, L; Yan, H; Yang, T; Zhuang, S | 1 |
| Bahn, A; Gold, E; Rodrigues, E; Sangkop, F; Singh, G | 1 |
| Ding, X; Fang, L; Gu, H; Liu, N; Shi, Y; Wang, H; Xu, L; Zhuang, S | 1 |
| Fan, CX; Li, L; Liang, YL; Lin, ZM; Liu, XN; Qu, JC; Xu, X; Zhang, RS; Zhao, HY; Zhao, L; Zhu, KS | 1 |
| Bao, W; Fang, L; Gu, H; Lin, T; Liu, N; Lu, J; Ma, S; Qiu, A; Shi, Y; Tao, M; Wang, Y; Xu, L; Zhuang, S | 1 |
| Ahn, KS; Baek, SH; Jung, SH; Ko, JH; Nam, D; Yang, MH | 1 |
| Ahmed, S; Chourasia, M; Haque, M; O'Sullivan, K; Ouseph, MM; Singh, AK | 1 |
| Gao, M; Huang, Q; Huang, Z; Zheng, C; Zheng, J | 1 |
| Fu, P; Guo, F; Ma, L; Ren, Q; Tao, S; Wang, B; Yang, L | 1 |
| Gong, B; Wang, W; Wang, Z; Xiang, T; Xie, J | 1 |
| Chen, JS; Chen, YY; Guo, X; Liu, C; Liu, YF; Sun, JY; Wang, MM; Wang, MX; Zhang, MQ; Zhang, YK | 1 |
| Chen, M; Ji, H; Liu, S; Song, W; Su, W; Zhang, D | 1 |
| Bakker, R; Bukkems, F; Cabău, G; Crişan, TO; Joosten, LAB; Klück, V; Mies, L; van Caam, A; van Emst, L | 1 |
| Chudasama, P; Patel, P; Patel, S; Raval, M; Soni, S | 1 |
3 review(s) available for uric acid and transforming growth factor beta
| Article | Year |
|---|---|
[Crystal-induced joint inflammation].
Topics: Acute Disease; Arthritis; Calcium; Calcium Pyrophosphate; Crystallization; Cytokines; Humans; Inflammation; Interleukins; Macrophages; Neutrophils; Prostaglandins; Synovial Fluid; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Uric Acid | 2003 |
[Mechanisms of gout inflammation].
Topics: Apoptosis; Arthritis, Gouty; Endocytosis; Humans; Immunity, Innate; Inflammation Mediators; Interleukin-1beta; Joints; Macrophages; Membrane Glycoproteins; Neutrophils; Phagocytosis; Receptors, Immunologic; Signal Transduction; Transforming Growth Factor beta; Triggering Receptor Expressed on Myeloid Cells-1; Uric Acid | 2011 |
The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis).
Topics: Apoptosis; Arthritis, Gouty; Biomarkers; Calcium Phosphates; Carrier Proteins; Chondrocalcinosis; Endothelial Cells; Gout; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Macrophages; Neutrophils; NLR Family, Pyrin Domain-Containing 3 Protein; Proteolysis; Transforming Growth Factor beta; Uric Acid | 2012 |
23 other study(ies) available for uric acid and transforming growth factor beta
| Article | Year |
|---|---|
Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1.
Topics: Acute Disease; Animals; Antibodies, Anti-Idiotypic; Disease Models, Animal; Dose-Response Relationship, Drug; Gout; Humans; Injections, Subcutaneous; Leukocyte Count; Male; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Time Factors; Transforming Growth Factor beta; Uric Acid | 1996 |
Growth factors VEGF and TGF-beta1 in peritoneal dialysis.
Topics: Biological Transport; Capillaries; Creatinine; Cross-Sectional Studies; Dialysis Solutions; Endothelial Growth Factors; Female; Glucose; Humans; Kidney Failure, Chronic; Lymphokines; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Regression Analysis; Transforming Growth Factor beta; Ultrafiltration; Urea; Uric Acid; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation.
Topics: Anti-Inflammatory Agents; Blister; Cantharidin; Cells, Cultured; Crystallization; E-Selectin; Endothelium, Vascular; Humans; Inflammation; Leukocytes; Macrophages; Monocytes; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Uric Acid | 2004 |
In vivo inosine protects alveolar epithelial type 2 cells against hyperoxia-induced DNA damage through MAP kinase signaling.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Cycle; Cells, Cultured; Cytoprotection; DNA Damage; DNA Glycosylases; DNA-Binding Proteins; Enzyme Activation; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Glutathione; Hyperoxia; Inosine; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Smad2 Protein; Trans-Activators; Transforming Growth Factor beta; Uric Acid | 2005 |
Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils.
Topics: Animals; Apoptosis; Cells, Cultured; Female; Gene Expression Regulation; Gout; GTP-Binding Proteins; Macrophages, Peritoneal; Male; Mice; Mice, Knockout; Neutrophils; Peritonitis; Phagocytosis; Protein Glutamine gamma Glutamyltransferase 2; Transforming Growth Factor beta; Transglutaminases; Uric Acid | 2006 |
Joint fluid antioxidants are decreased in osteoarthritic joints compared to joints with macroscopically intact cartilage and subacute injury.
Topics: Age Factors; Cartilage, Articular; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Female; Free Radical Scavengers; Glutathione; Humans; Interleukin-6; Knee Joint; Male; Middle Aged; Nitrates; Nitrites; Osteoarthritis, Knee; Pain; Reactive Oxygen Species; Superoxide Dismutase; Synovial Fluid; Transforming Growth Factor beta; Uric Acid | 2008 |
Inflammasome-mediated regulation of hepatic stellate cells.
Topics: Actins; Animals; Apoptosis Regulatory Proteins; Calcium Signaling; Carbon Tetrachloride; CARD Signaling Adaptor Proteins; Carrier Proteins; Cell Line, Transformed; Chemotaxis; Collagen Type I; Cytoskeletal Proteins; Gene Expression; Hepatic Stellate Cells; Humans; Inflammation; Inositol 1,4,5-Trisphosphate; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Mice, Knockout; NLR Family, Pyrin Domain-Containing 3 Protein; Platelet-Derived Growth Factor; Thioacetamide; Transforming Growth Factor beta; Uric Acid | 2009 |
Peroxynitrite mediates glomerular lesion of diabetic rat via JAK/STAT signaling pathway.
Topics: Animals; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Immunohistochemistry; Janus Kinase 2; Kidney Glomerulus; Male; Microscopy, Electron, Transmission; Peroxynitrous Acid; Phosphorylation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Transforming Growth Factor beta; Tyrosine; Uric Acid | 2009 |
Relative efficacy of casein or soya protein combined with palm or safflower-seed oil on hyperuricaemia in rats.
Topics: Albumins; Analysis of Variance; Animals; Blood Urea Nitrogen; Caseins; Cholesterol; Creatinine; Diet; Dietary Fats; Dietary Proteins; Dietary Supplements; Drug Therapy, Combination; Fibrosis; Glycine max; Hyperuricemia; Insulin; Interferon-gamma; Kidney; Kidney Calculi; Male; Nephritis, Interstitial; Nitric Oxide; Oxonic Acid; Palm Oil; Plant Oils; Rats; Rats, Wistar; Safflower Oil; Soybean Proteins; Transforming Growth Factor beta; Triglycerides; Tumor Necrosis Factor-alpha; Tyrosine; Uric Acid | 2010 |
EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.
Topics: Animals; Chemokines; Cytokines; Disease Progression; ErbB Receptors; Fibroblasts; Fibrosis; Gefitinib; Hyperuricemia; Inflammation; Kidney; Kidney Diseases; Male; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Risk Factors; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1; Uric Acid | 2015 |
Uric acid: a modulator of prostate cells and activin sensitivity.
Topics: Activins; Cell Line, Tumor; Glucose Transport Proteins, Facilitative; Humans; Male; Probenecid; Prostate; Prostatic Neoplasms; RNA, Messenger; Tissue Array Analysis; Transforming Growth Factor beta; Uric Acid | 2016 |
Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats.
Topics: Animals; Anion Transport Proteins; Cytokines; Disease Models, Animal; Disease Progression; Fibroblasts; Hyperuricemia; Kidney Diseases; Kidney Function Tests; Macrophages; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Phosphorylation; Protein Kinase Inhibitors; Proteinuria; Rats; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Uric Acid | 2017 |
[Effect of febuxostat on epithelial-to-mesenchymal transition of kidney tubules, serum interleukin-6 and transforming growth factor β(1) in hyperuricemic rats].
Topics: Animals; Antigens, CD; Cadherins; Chalcone; Creatinine; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Febuxostat; Gout Suppressants; Hyperuricemia; Interleukin-6; Kidney Tubules; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Transforming Growth Factor beta1; Uric Acid | 2017 |
Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
Topics: Animals; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Fibroblasts; Fibrosis; Histones; Hyperuricemia; Kidney Diseases; Mice; Mitogen-Activated Protein Kinase 3; Phosphorylation; RNA, Small Interfering; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta; Uric Acid; Xanthine Oxidase | 2019 |
Theacrine attenuates epithelial mesenchymal transition in human breast cancer MDA-MB-231 cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Fibronectins; Humans; Nuclear Proteins; Snail Family Transcription Factors; Transforming Growth Factor beta; Twist-Related Protein 1; Uric Acid; Vimentin | 2019 |
Suppression of monosodium urate crystal-induced inflammation by inhibiting TGF-β-activated kinase 1-dependent signaling: role of the ubiquitin proteasome system.
Topics: Animals; Antioxidants; Fibroblasts; Gout; Humans; Inflammation; Lactones; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Proteasome Endopeptidase Complex; Resorcinols; Signal Transduction; Synovial Membrane; Transforming Growth Factor beta; Ubiquitin; Uric Acid | 2021 |
Theacrine alleviates chronic inflammation by enhancing TGF-β-mediated shifts via TGF-β/SMAD pathway in Freund's incomplete adjuvant-induced rats.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Chronic Disease; Freund's Adjuvant; Inflammation; Joints; Lipids; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Uric Acid | 2020 |
Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling.
Topics: Administration, Oral; Animals; Fibrosis; Flavonols; Gene Expression Regulation; Hyperuricemia; Interleukin-6; Janus Kinase 2; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Smad3 Protein; STAT3 Transcription Factor; Transforming Growth Factor beta; Uric Acid | 2021 |
Serum Uric Acid as a Diagnostic Biomarker for Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Topics: Arthritis, Rheumatoid; Biomarkers; Humans; Interleukin-1; Interleukin-6; Lung Diseases, Interstitial; Transforming Growth Factor beta; Uric Acid | 2022 |
Synthesis and biological evaluation of geniposide derivatives as inhibitors of hyperuricemia, inflammatory and fibrosis.
Topics: Animals; Fibrosis; Hyperuricemia; Inflammation; Iridoids; Kidney Diseases; Mice; Molecular Docking Simulation; Transforming Growth Factor beta; Uric Acid; Xanthine Oxidase | 2022 |
Anserine beneficial effects in hyperuricemic rats by inhibiting XOD, regulating uric acid transporter and repairing hepatorenal injury.
Topics: Alanine Transaminase; Alkaline Phosphatase; Allopurinol; Animals; Anserine; ATP-Binding Cassette Transporters; Creatinine; Glucose Transport Proteins, Facilitative; Hyperuricemia; Hypoxanthines; Kidney; Liver; Malondialdehyde; Organic Anion Transporters; Potassium; Rats; Superoxide Dismutase; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Uric Acid; Xanthine Oxidase | 2022 |
TGF-β is elevated in hyperuricemic individuals and mediates urate-induced hyperinflammatory phenotype in human mononuclear cells.
Topics: Gout; Humans; Hyperuricemia; Leukocytes; Leukocytes, Mononuclear; Transforming Growth Factor beta; Uric Acid | 2023 |
Roflumilast alleviates adenine-induced chronic kidney disease by regulating inflammatory biomarkers.
Topics: Adenine; Animals; Antioxidants; Biomarkers; Calcium; Creatinine; Kidney; Magnesium Chloride; Male; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Transforming Growth Factor beta; Urea; Uric Acid | 2023 |